recent surgery (< 3 months)
previous chemotherapy
previous transfusion of blood products
neurodevelopmental disorders (including Trisomy 21)
supplemental oxygen requirement (< 3 months)
asthma requiring regular therapy
obstructive sleep apnea
the presence of concurrent infection or inflammation
a known allergy to dexmedetomidine hydrochloride

NCT02299063_exc_T1
Procedure
surgery
NCT02299063_exc_T2
Temporal
recent
NCT02299063_exc_T3
Temporal
< 3 months
NCT02299063_exc_T4
Temporal
previous
NCT02299063_exc_T5
Procedure
chemotherapy
NCT02299063_exc_T6
Temporal
previous
NCT02299063_exc_T7
Procedure
transfusion of blood products
NCT02299063_exc_T8
Condition
neurodevelopmental disorders
NCT02299063_exc_T9
Condition
Trisomy 21
NCT02299063_exc_T10
Procedure
supplemental oxygen
NCT02299063_exc_T11
Mood
requirement
NCT02299063_exc_T12
Temporal
< 3 months
NCT02299063_exc_T13
Condition
asthma
NCT02299063_exc_T14
Procedure
regular therapy
NCT02299063_exc_T15
Condition
obstructive sleep apnea
NCT02299063_exc_T16
Temporal
concurrent
NCT02299063_exc_T17
Condition
infection
NCT02299063_exc_T18
Condition
inflammation
NCT02299063_exc_T19
Scope
infection or inflammation
NCT02299063_exc_T20
Condition
allergy
NCT02299063_exc_T21
Drug
dexmedetomidine hydrochloride